<DOC>
	<DOCNO>NCT02164110</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ( Immunogenicity ) Safety Euvichol Healthy Adults Children .</brief_summary>
	<brief_title>To Evaluate Efficacy ( Immunogenicity ) Safety Euvichol Healthy Adults Children</brief_title>
	<detailed_description>A randomize , single blind , multicenter , therapeutic confirmatory study ass efficacy ( immunogenicity ) safety Euvichol healthy adult child</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Written inform consent study participation voluntarily provide individual his/her legally acceptable representative . 2 . Age 1 ~ 40 year 3 . An individual follow study period capable complying study requirement . 1 . History hypersensitivity reaction preventative vaccination . 2 . Immune function disorder include immunodeficiency disease . 3 . An individual thought difficulty participate study due severe chronic disease , base judgment investigator . 4 . 38â„ƒ high body temperature measure prior investigational product dosing . 5 . Abdominal pain , nausea , vomit , decrease appetite within 24 hour prior study initiation . 6 . Diarrhea administration antidiarrheal drug antibiotic treat diarrhea within 1 week prior study initiation . 7 . Other vaccination within 1 week prior study initiation plan vaccination study . 8 . Diarrhea abdominal pain last 2 week longer within 6 month prior study initiation . 9 . Participation another clinical trial investigational product dose within 1 month prior study initiation . 10 . Pregnant lactating woman . 11 . An individual thought difficulty participate study due reason , base judgment investigator 12 . Applicable Pivotal study : history cholera vaccination history cholera .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>